ALMAC Discovery Secures European Patent Protection for ALM201

Almac Discovery, a research driven oncology company that is dedicated to the discovery and development of novel and innovative approaches to the treatment of cancer, has announced that it has been granted patent protection (Patent Number 2040728) for its novel therapeutic drug, ALM201, in Europe, one of the largest Biopharmaceutical markets in the world. This adds to patent protection already granted in a further 6 countries – Australia, China, Israel, Japan, New Zealand and South Africa, strengthening the company’s growing portfolio globally.

#AlmacDiscovery #biopharmaceutical #noveltherapeuticdrug #oncology